Pacer Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,517
Closed -$106K 2607
2024
Q2
$106K Buy
2,517
+1,809
+256% +$99.5K ﹤0.01% 2283
2024
Q1
$48.9K Buy
+708
New +$44.8K ﹤0.01% 3173
2022
Q1
Sell
-803
Closed -$62K 2364
2021
Q4
$62K Buy
+803
New +$70.9K ﹤0.01% 2133
2021
Q3
Sell
-899
Closed -$112K 1442
2021
Q2
$112K Buy
899
+295
+49% +$35.2K ﹤0.01% 1349
2021
Q1
$80K Sell
604
-415
-41% -$56.8K ﹤0.01% 1320
2020
Q4
$135K Sell
1,019
-210
-17% -$25.4K ﹤0.01% 1308
2020
Q3
$125K Buy
+1,229
New +$106K ﹤0.01% 1229
2018
Q4
Sell
-4,171
Closed -$329K 714
2018
Q3
$329K Buy
+4,171
New +$272K 0.01% 938
2018
Q1
Sell
-2,625
Closed -$138K 1067
2017
Q4
$138K Sell
2,625
-16,585
-86% -$886K 0.01% 932
2017
Q3
$905K Buy
+19,210
New +$773K 0.08% 348

Other funds holding EXAS

Pacer Advisors's EXAS Position: Q3 2024 in Review

Pacer Advisors sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 2,517 shares — an estimated $106K sold.

Pacer Advisors first reported a position in EXAS in Q3 2017 and held it in 10 quarters. The position peaked at $905K in Q3 2017. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Pacer Advisors reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 2,517 Exact Sciences shares in Q3 2024, an estimated $106K.
  • Pacer Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 10 quarters.
  • Pacer Advisors's Exact Sciences position peaked at $905K in Q3 2017.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.